00:00
All right then,
this session we'll look
at plaque morphology
and the complications
that occur,
as a difference between
different kinds of plaque.
00:11
Not all plaque is created equal.
00:14
Here's where we
are on our roadmap.
00:17
We've already talked
about risk factors
and how we build a plaque.
00:20
Now we're going to talk about
differences in the way the plaques look,
and they behave.
00:27
In interesting phenomena,
that was identified
in the 60s and 70s
by Dr. Glagov
is this phenomena where as we
build atherosclerotic plaque
going from left to right.
00:41
As we get more and more
plaque accumulation,
the vessels can accommodate
this by undergoing remodeling.
00:49
And so for the
first four circles,
even as we get more and
more atherosclerotic plaque
that compromises the
lumen more and more.
00:58
The lumen size as the vessel
has expanded hasn't changed.
01:02
It's the same lumen size.
01:05
However, we do reach a point where
the vessel can't remodel anymore.
01:09
And as we accumulate
more and more plaque,
the last two circles
on the right,
we do get a smaller
and smaller lumen
with less and less
flow going down that.
01:20
But up to a certain point,
we can't see any
significant atherosclerosis.
01:24
This has implications
when we do angiography
because angiography,
putting in radio contrast
material into a vessel
only looks at the
luminal diameter,
and can't really
assess the accumulation
of atherosclerotic plaque,
because of this outward
remodeling of the vessel,
the Glagov phenomenon.
01:44
So that's one important point.
01:46
We do reach a point,
also where we have clinical
significance, and this,
this Rubicon is typically
identified as about 70% stenosis.
01:56
At this point,
we don't have any more ability
of the vessel wall to remodel
and that 70% luminal stenosis
is starting to
limit blood supply.
02:07
Let's look at that.
02:09
So on this graph,
we're looking at coronary
flow reserve on the Y axis,
we're looking at the degree of
stenosis or diameter narrowing
on the X axis,
and about that critical
stenosis that 70% Rubicon
resting flow is not compromised,
so we will have no
symptomatology at rest.
02:30
But if we increase activity,
if we increase
demand on the heart,
if we increase heart
rate, or blood pressure,
then that 70% percent stenosis
starts to significantly impact
the amount of blood
that can get in.
02:46
And we will start to
have symptomatology,
we will have supply
demand mismatch,
and patients will start
presenting with anginal symptoms.
02:56
Usually, when angina occurs,
patients don't continue
to exercise through that
or to continue their
activity through that,
and they get back to
resting conditions.
03:05
And so we avoid a heart attack.
03:07
So angina is a warning signal,
and that 70% stenosis
starts occurring then.
03:14
Let's look at the progression
of atherosclerosis.
03:16
A normal vessel is shown
here on this trichrome stain,
and the arrow is pointing to a little
bit of an intimal proliferative process.
03:24
So what's now
highlighted in green
is a very small,
early intimal lesion.
03:30
This is not going to be
in any way shape or form,
impeding vascular flow.
03:35
And even as this is developing,
we're starting to get
outward remodeling,
so we would see no
diminution of flow.
03:42
Further on,
once we reach that 70% stenosis,
again,
on a trichrome stain here,
we will develop so
called stable angina,
certain levels of activity,
certain demands on the heart
will exceed the
capacity of the vessel
to perfuse that heart,
and we'll get symptomatology.
04:01
We may get chest pain or angina,
we may get symptoms of
congestive heart failure
with shortness of breath.
04:08
And now highlighted in green,
you can see the degree of
atherosclerotic plaque development.
04:15
It looks like it may
be even more than 70%.
04:18
But that's because in this vessels,
we've taken it out of the body
without pressure in the lumen.
04:23
The lumen has been collapsed
by all of that surrounding
smooth muscle and
extracellular matrix.
04:30
And then,
importantly,
atherosclerosis doesn't just
progress by the accumulation
of atherosclerotic plaque.
04:41
There can be acute events
where the plaque ruptures.
04:46
And now we expose to
the following blood
underlying matrix including
Von Willebrand factor
and tissue factor
and other things
that will cause an
acute thrombosis.
04:59
So in this vessel that's
shown here in the final panel.
05:02
Now in green,
that's the degree of atherosclerosis,
there really wasn't that
much atherosclerosis,
maybe 30 or 40% overall.
05:12
But this plaque wasn't stable,
it ruptured.
05:16
And now we have a superimposed
thrombus that's in the middle,
that was completely occlusive.
05:21
And we went from maybe a
30, or 40%,
chronic stenosis to now
100%, acute occlusion.
05:29
And this patient suffered a myocardial
infarct as a result of that.
05:33
So let's talk about those
changes now that occur, acutely.
05:39
Atherosclerosis is a disease
that has a long horizon.
05:45
There is a very long
preclinical phase,
it takes decades
fortunately, in most of us,
to develop any significant
atherosclerotic plaque.
05:54
And we go from a normal artery,
first to a fatty streak.
05:58
Fatty streak is where we're
getting the accumulation of lipid
underlying dysfunctional
endothelium
with or without some macrophages
that are also taking up that
liquid to become foam cells.
06:11
That is actually
reversible process.
06:12
That's why you see that
double headed arrow,
and we can actually go back
to a completely normal artery.
06:19
That fatty streak,
however, can progress,
we can accumulate more
inflammatory cells,
which will recruit and activate
more smooth muscle cells,
which will lay down more matrix
and eventually we
get a combination
fibrofatty plaque or
atherosclerotic plaque.
06:34
From that point, there are a couple
different ways that we can diverge.
06:38
So we can have
progressive accumulation
of material.
06:42
We have a stable plaque and it just
keeps getting more and more and more
driven by the usual processes.
06:50
That will happen over decades.
06:52
And eventually at some point,
we get that critical stenosis,
we exceed the capacity
of the vessel to remodel,
we get beyond 70%
chronic stenosis,
and then we get symptomatology
that is the kind of
the critical stenosis.
07:08
The other way that this can
go from a fibrofatty plaque
is so something so called
a vulnerable plaque.
07:14
This plaque is unstable for
reasons that we'll talk about
in the subsequent slides.
07:19
But from a vulnerable plaque,
we can actually have a vessel
wall that completely ruptures
or formation of an
aneurysm that ruptures
and we can have a
catastrophic event that way.
07:32
Or we can have that plaque as we
saw on the previous slide, break.
07:37
And now we're
exposing underlying,
very thrombogenic matrix elements
and necrotic debris and other things
that will now take us from
whatever degree
of stenosis we had
to a complete
occlusion by thrombus.
07:51
So it takes a long time to
get to a point where then
something happens.
07:56
Okay?
Preclinical phase
clinical phase.